Safety of Co-Administered Cannabidiol (CBD) and alcohol: a Phase I study
Abstract Background: This Phase I randomized controlled trial aimed to assess the safety and tolerability of cannabidiol (CBD) and alcohol…
Justin C. Strickland
Abuse potential assessment of novel central nervous system active and psychedelic substances for controlled substances act scheduling recommendations
Abstract Introduction: Abuse potential assessment of drugs with central nervous system activity is a critical component of the development of…
Does acute cannabidiol (CBD) use impair performance? A meta-analysis and comparison with placebo and delta-9-tetrahydrocannabinol (THC)
Abstract Cannabidiol (CBD) is widely used and believed to be non-intoxicating, lacking acute performance effects (e.g., non-impairing). However, a synthesis…
Online survey of medicinal cannabis users: Qualitative analysis of patient-level data
Abstract Aim: To characterize perceived benefits and challenges experienced by medicinal cannabis users. Methods: An anonymous online survey collected demographics,…
A Cross-Sectional and Prospective Comparison of Medicinal Cannabis Users and Controls on Self-Reported Health
Abstract Introduction: Despite widespread legalization, the impact of medicinal cannabis use on patient-level health and quality of life (QOL) has…
Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use in an Observational Trial
Abstract Background: Anxiety and depressive disorders are highly prevalent. Patients are increasingly using medicinal cannabis products to treat these disorders,…